HMGB1 and small cell lung carcinoma: Results of this current study suggested that polymorphisms in HMGB1 showed an association with the risk of lung cancer in non-smokers and female population and it could be used as a biomarker for the risk of lung cancer, especially for the risk of LAD and SCLC.